Mirae Asset Global Etfs Holdings Ltd. Allogene Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 305,895 shares of ALLO stock, worth $624,025. This represents 0.0% of its overall portfolio holdings.
Number of Shares
305,895
Previous 247,564
23.56%
Holding current value
$624,025
Previous $693,000
6.06%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALLO
# of Institutions
178Shares Held
143MCall Options Held
37.5KPut Options Held
77.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$38.2 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$33.5 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$22.2 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$16.3 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$14.8 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $293M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...